Liming Lin
- Topics
- Ubiquitin and proteasome pathways (3 papers)Histone Deacetylase Inhibitors Research (2 papers)Hematopoietic Stem Cell Transplantation (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Liming Lin
7 papers receiving 192 citations
Hit Papers
Peers
Comparison fields: 5 of 48
- Molecular Biology 99
- Cancer Research 62
- Oncology 40
- Hematology 33
- Immunology 29
Countries citing papers authored by Liming Lin
This map shows the geographic impact of Liming Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liming Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liming Lin more than expected).
Fields of papers citing papers by Liming Lin
This network shows the impact of papers produced by Liming Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liming Lin. The network helps show where Liming Lin may publish in the future.
Co-authorship network of co-authors of Liming Lin
This figure shows the co-authorship network connecting the top 25 collaborators of Liming Lin. A scholar is included among the top collaborators of Liming Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liming Lin. Liming Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | Glycolytic enzyme PFKL governs lipolysis by promoting lipid droplet–mitochondria tethering to enhance β-oxidation and tumor cell proliferationbreakdown → | 49 |
| 4 | 5 | |
| 5 | 9 | |
| 6 | 19 | |
| 7 | 79 | |
| 8 | The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis. | 31 |
About Liming Lin
Liming Lin is a scholar working on Hematology, Biochemistry and Cancer Research, having authored 8 papers that have together received 194 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (3 papers), Histone Deacetylase Inhibitors Research (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). The work is most often cited by research in Transplantation (19 citations), Cancer Research (62 citations) and Hematology (33 citations). Liming Lin has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zhimin Lu, Jingjing Tao, Shudi Luo, Dong Guo, Chunmin Ma, Yuhui Jiang, Yan Dong, Fei Shao, Dongming Xing and Yugang Wang. Their work appears in journals such as Nature Structural & Molecular Biology, Cancer Letters and Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.